Active • Host: Insect cells • AA: 6-415 • Tag: N-terminal His • MW: 50.12 kDa
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

ROCK1 (human, recombinant)

Item No. 32757

Technical Information
Synonyms
  • p160 ROCK1
  • Renal Carcinoma Antigen NY-REN-35
  • Rho-associated, Coiled-coil-containing Protein Kinase 1
  • Rho-associated Protein Kinase 1
Purity
≥90% estimated by SDS-PAGE
Source
Active recombinant N-terminal His-tagged human ROCK1 expressed in insect cells
Amino Acids
6-415
MW
50.12 kDa
20 mM HEPES, pH 7.5, with 150 mM sodium chloride, 1 mM DTT, and 5% gylcerol
UniProt Accession №
Q13464
Shipping & Storage Information
Storage
-80°C
Shipping
Dry ice in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Kinase Resource Center
    Discover Products & Resources for Kinase Research
    • Kinase inhibitors, screening libraries, assay kits, & more
    • Tools to study kinase signaling pathways:
      • Growth factor signaling
      • PI3K/Akt/mTOR
      • MAPKs (ERK, p38, & JNK)
      • JAK/STAT signaling
    • Articles, resources, & advice
    EXPLORE NOW
    Product Description

    Rho-associated protein kinase 1 (ROCK1) is a serine/threonine kinase that has roles in cytoskeletal organization, as well as cell survival, proliferation, and apoptosis.1,2 It exists as a homodimer where each monomer is composed of an N-terminal kinase domain, a coiled-coil region that contains the Rho-binding domain, and a C-terminal pleckstrin homology (PH) domain that contains a cysteine-rich C1 domain and acts as an autoinhibitory region.3,2 Rock1 mRNA is expressed in all tissues except in the muscle and brain, and the protein is localized predominantly in the cytosol but also associates with the plasma membrane and centrosomes.2,1 Binding of ROCK1 to GTP-bound RhoA induces activation of ROCK1, which phosphorylates a variety of downstream targets, including myosin light chain (MLC) phosphatase 1 (MYPT1) and MLC2, that have diverse roles in cytoskeletal organization.2 The C-terminal autoinhibitory region of ROCK1 is cleaved by caspase-3 during the execution phase of apoptosis, resulting in constitutively active ROCK1 and plasma membrane blebbing, a hallmark of apoptosis.1,2 ROCK1 is overexpressed in tumors from patients with various solid tumors, including hepatocellular carcinoma, glioblastoma, or melanoma, and increased tumor ROCK1 mRNA transcript levels are correlated with increased metastasis and reduced overall survival in patients with breast cancer.4,5 Cayman’s ROCK1 (human, recombinant) protein can be used for ELISA, enzyme activity assay, and Western blot (WB) applications.

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Hartmann, S., Ridley, A.J., and Lutz, S. The function of Rho-associated kinases ROCK1 and ROCK2 in the pathogenesis of cardiovascular disease. Front. Pharmacol. 6, 276 (2015).

    2. Julian, L., and Olson, M.F. Rho-associated coiled-coil containing kinases (ROCK): Structure, regulation, and functions. Small GTPases 5, e29846 (2014).

    3. Haga, R.B., Garg, R., Collu, F., et alRhoBTB1 interacts with ROCKs and inhibits invasion. Biochem. J. 476(17), 2499-2514 (2019).

    4. Hu, C., Zhou, H., Liu, Y., et alROCK1 promotes migration and invasion of non‑small‑cell lung cancer cells through the PTEN/PI3K/FAK pathway. Int. J. Oncol. 55(4), 833-844 (2019).

    5. Lane, J., Martin, T.A., Watkins, G., et alThe expression and prognostic value of ROCK I and ROCK II and their role in human breast cancer. Int. J. Oncol. 33(3), 585-593 (2008).